Recent perspectives into biochemistry of decavanadate

Table 2 Decavanadate in vitro studies in 2001-2010

Protein/effect	Vanadate species	Yr	Ref.
DNA-binding protein	V10	2002	[70]
Methemoglobin reductase inhibition	V10	2003	[73]
Actomyosin ATPase inhibition	V10	2004	[20]
Muscle contraction regulation	V10	2004	[21]
ATP sensitive cation -channel	V10	2004	[76]
TRPM4 cation channels	V10	2004	[71]
G-Actin polymerization inhibitor	V10, V4	2006	[36]
RNA triphosphatase	V10	2006	[72]
P2X receptor antagonist	V10	2006	[74]
Insulin mimetics	V10 compounds	2007	[57]
Back-door binding to myosin	V10	2007	[22]
Porin (VDC) modulator	V10	2007	[75]
Mitochondrial membrane depolarization	V10, V1	2007	[54]
Mitochondrial oxygen consumption	V10, V1	2007	[55]
Extracellular matrix mineralization	V10, V1	2008	[77]
Cardiomyocytes necrotic cell death	V10, V1	2008	[78]
Gelatine-mixtures	V10	2008	[79]
Adipocytes glucose accumulation	V10	2009	[68]
Actin oxidation and vanadyl formation	V10	2009	[52]
Anticancer activity	V10 compounds	2009	[58]
ATPase activity in synaptic membranes	V10	2009	[80]
Membrane models interaction	V10	2009	[81]
DNA cleavage	V10	2010	[82]
Actin structure and function	V10	2010	[2]
Anticancer activity	V10 compounds	2010	[59]

TRPM4: Transient receptor potential cation channel subfamily M member 4.